Edesa Biotech CEO granted 5,324 restricted units
Nijhawan Pardeep reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nijhawan Pardeep reported acquisition or exercise transactions in this Form 4 filing.
Edesa Biotech, Inc. Chief Executive Officer and 10% owner Pardeep Nijhawan received a grant of 5,324 restricted share units on 2026-08-03, vesting in full upon grant under the 2019 Equity Incentive Compensation Plan. After this award, he directly holds 893,386 common shares, plus additional indirect holdings through affiliated entities and a family trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
Insider Trade Summary
Grant/Award: 5,324 shares
Grant/Award
1 txn
Insider
Nijhawan Pardeep
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1 | 5,324 | $0.00 | $0.00 |
| Holding | Common Shares F2 | -- | -- | -- |
| Holding | Common Shares F3 | -- | -- | -- |
| Holding | Common Shares F2 | -- | -- | -- |
| Holding | Common Shares F2 | -- | -- | -- |
Holdings After Transaction:
Common Shares — 893,386 shares (Direct);
Common Shares — 402,702 shares (Indirect, Held by Pardeep Nijhawan Medicine Professional Corporation);
Common Shares — 32,609 shares (Indirect, Held by The New Nijhawan Family Trust 2015);
Common Shares — 32,013 shares (Indirect, Held by The Digestive Health Clinic Inc.);
Common Shares — 53,104 shares (Indirect, Held by 1968160Ontario Inc.)
Footnotes (3)
- F1. Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
- F2. Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3. Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Restricted share units granted: 5,324 units
Direct common shares held: 893,386 shares
Indirect shares via Pardeep Nijhawan Medicine Professional Corporation: 402,702 shares
+3 more
6 metrics
Restricted share units granted
5,324 units
Grant to CEO Pardeep Nijhawan on 2026-08-03
Direct common shares held
893,386 shares
Direct holdings after the reported award
Indirect shares via Pardeep Nijhawan Medicine Professional Corporation
402,702 shares
Indirect holdings; beneficial ownership disclaimed except for pecuniary interest
Indirect shares via The New Nijhawan Family Trust 2015
32,609 shares
Trust holdings; beneficial ownership disclaimed except for pecuniary interest
Indirect shares via The Digestive Health Clinic Inc.
32,013 shares
Indirect holdings; entity wholly owned by reporting person
Indirect shares via 1968160 Ontario Inc.
53,104 shares
Indirect holdings; entity wholly owned by reporting person
Key Terms
restricted share units, 2019 Equity Incentive Compensation Plan, pecuniary interest, beneficial ownership
4 terms
2019 Equity Incentive Compensation Plan financial
"pursuant to the Issuer's 2019 Equity Incentive Compensation Plan"
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
beneficial ownership financial
"disclaims beneficial ownership of these securities except to the extent"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Edesa Biotech (EDSA) report for CEO Pardeep Nijhawan?
Edesa Biotech reported that CEO Pardeep Nijhawan received a grant of 5,324 restricted share units on 2026-08-03. The award vested in full upon grant under the company’s 2019 Equity Incentive Compensation Plan and is reflected as an acquisition of common shares.
Under which equity plan were the Edesa Biotech (EDSA) restricted units granted to the CEO?
The 5,324 restricted share units granted to CEO Pardeep Nijhawan were issued under Edesa Biotech’s 2019 Equity Incentive Compensation Plan. The filing notes that these units vested in full upon grant pursuant to this equity incentive program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
